Evolus, Inc. (EOLS)

NASDAQ

$7.45

$+0.08

(+1.06%)

Pre-Market

Evolus, Inc. (EOLS) Live Price Chart

Last updated: ⁦2026-10-21 09:16:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Evolus, Inc. (EOLS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.45, with a market capitalization of $486.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.86 to $9.31. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$486.13M
Open	$7.37
Day's High	$39.50
Day's Low	$2.85
Previous Close	$7.37
Volume	109.00
Average Volume	896.80K
P/E Ratio	--
52-Week High	$9.31
52-Week Low	$3.86
Dividend Yield	--
Earnings Date	--

Evolus, Inc. (EOLS) Pre-Market Stock Price

Evolus, Inc. (EOLS) is trading at $7.45 in pre-market trading as of 2026-10-21 08:29:00, up 1.06% ($0.08) from the previous close of $7.37

Pre-market trading shows how investors are pricing EOLS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Evolus, Inc. (EOLS) 7-Day Stock Price Change

Over the past seven days, Evolus, Inc. (EOLS) moved from $7.75 to $7.45, representing a decline of 3.90% ($0.30).

The stock traded between $7.02 and $7.83 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 756.15 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

EOLS 52-Week Price Position

Position in Range: 65.8%

52W Low$3.86

52W High$9.31

EOLS is currently trading at $7.45, placing it 65.8% of the way from its 52-week low of $3.86 to its 52-week high of $9.31. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Evolus, Inc. (EOLS)?

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Evolus, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	353
Exchange	NASDAQ
Company Website	https://www.evolus.com

How to Buy Evolus, Inc. (EOLS) Stock on MEXC

Eligible investors can buy real shares of Evolus, Inc. (EOLS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EOLS and Place Your Order

Open the RealStocks trading page and search for EOLS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Evolus, Inc. (EOLS) stock price today?

Evolus, Inc. (EOLS) is currently trading at $ 7.45, up 1.06% ($0.08) from the previous close of $ 7.37. Intraday prices update in real time during regular trading hours.

2.Is EOLS stock going up or down today?

As of 2026-10-21 08:29:00, EOLS is trading at $ 7.45, up 1.06% ($0.08) from its previous close of $ 7.37. The stock has traded between $ 2.85 and $ 39.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is EOLS pre-market price?

As of 2026-10-21 08:29:00, EOLS is trading at $ 7.45 in pre-market trading, up 1.06% ($0.08) from the previous close of $ 7.37. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EOLS after-hours price?

As of 2026-10-21 08:29:00, EOLS is trading at $ 7.37 in after-hours trading, unchanged from the regular-session close of $ 7.37. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EOLS stock trading now?

EOLS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EOLS sit relative to its 52-week high and low?

Over the past 52 weeks, EOLS has traded between a low of $ 3.86 and a high of $ 9.31. At $ 7.45, the stock is positioned 65.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Evolus, Inc. in?

Evolus, Inc. (EOLS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Evolus, Inc.'s market capitalization and where is it listed?

Evolus, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 486.13M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EOLS valued in terms of P/E ratio and EPS?

EOLS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.52. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Evolus, Inc. pay a dividend?

Evolus, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.